CVRx is a leading brand that offers an innovative heart failure treatment option called Barostim™. As the world's first neuromodulation device for heart failure management, Barostim provides a novel therapeutic solution for individuals experiencing heart failure symptoms. If traditional medications have not effectively improved your symptoms and quality of life, Barostim may be the right therapy for you.

Barostim is a simple and implantable device that stimulates baroreceptors, natural sensors in our body that regulate heart, kidney, and vascular function. By reducing the workload on the heart and helping it pump more efficiently, Barostim can potentially alleviate the symptoms of heart failure. Clinical studies have demonstrated positive outcomes for patients using Barostim, including improved exercise capacity, quality of life, and functional status.

Additionally, 94% of patients experienced significant improvement in at least one measure. To see if you qualify for Barostim, simply answer a few short questions and connect with a cardiologist in your area for an evaluation. CVRx's mission is to turn heart failure into heart success, offering hope and improved outcomes for patients